The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Anaplastic Thyroid Carcinoma Immunotherapy

Targeted and immune therapy for an aggressive undifferentiated thyroid cancer

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Onkoloji department. Book Appointment →

What is Anaplastic Thyroid Carcinoma Immunotherapy?

Anaplastic thyroid carcinoma usually presents in older adults as a rapidly enlarging neck mass with hoarseness, dysphagia, dyspnea, and frequent regional or distant metastases. Survival was historically measured in months, but recent advances have improved outcomes when therapy is initiated promptly.

Tumor genotyping for BRAF V600E, NTRK fusions, RET fusions, and tumor mutational burden is now standard. Patients with BRAF V600E mutation receive dabrafenib and trametinib, often combined with surgical or radiation consolidation when disease responds.

Immune checkpoint inhibitors such as pembrolizumab and combination with kinase inhibitors are used in selected patients, particularly those with high tumor mutational burden or progression on targeted therapy. Airway preservation, nutrition, and palliative care planning remain integral throughout treatment.

Symptoms

Rapidly enlarging neck mass over weeks
Hoarseness from recurrent laryngeal nerve invasion
Stridor or dyspnea from airway compression
Dysphagia and pressure sensation
Regional and distant metastases at diagnosis

Risk Factors

Long-standing differentiated thyroid cancer
Older adult age and prior goiter
Iodine deficiency in endemic regions
Prior radiation exposure to the neck
BRAF V600E or other actionable mutations

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • When a thyroid mass enlarges quickly
  • When hoarseness, stridor, or dysphagia develops
  • When biopsy confirms anaplastic histology
  • When airway compromise is suspected
  • When tertiary referral is needed for therapy

Treatment Methods

01
Rapid molecular profiling for BRAF and NTRK
02
Dabrafenib and trametinib in BRAF V600E disease
03
Pembrolizumab combinations in selected cases
04
Concurrent or sequential surgery and radiation
05
Airway management with tracheostomy if needed
06
Nutritional support and palliative care
07
Multidisciplinary review at a high-volume center

Which Department to Visit?

You can visit our Onkoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Onkoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.